Inflammasomes as a Prognostic Marker and Possible Therapeutic Target in Multiple Sclerosis: A Rapid Review of the Literature. PPCR [Internet]. 2023 Sep. 3 [cited 2024 Nov. 24];9(2). Available from: https://journal.ppcr.org/index.php/ppcrjournal/article/view/265